Takuya Miwa

Early Clinical Development Dept.
Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
Tokyo, Tokyo, Japan

Presentation(s):

• OC 69.4 - Safety, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous Injection of NXT007, an Emicizumab-Based Next-Generation Bispecific Antibody, in Healthy Volunteers (NXTAGE Study)

  Wednesday, June 28, 2023
  11:00 – 11:15 ET